Global Scoring Balloon Catheters Market Size By Type (Polyurethane, Nylon), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Scoring Balloon Catheters Market was valued at USD 156.4 million in 2023 and is projected to reach USD 262.1 million by 2031, expanding at a CAGR of 6.8% during the forecast period from 2023 to 2031. This growth is attributed to the increasing prevalence of cardiovascular diseases, rising preference for minimally invasive procedures, and the continuous advancement in balloon catheter technologies. Scoring balloon catheters are specialized medical devices used primarily in percutaneous transluminal angioplasty procedures for treating atherosclerotic lesions, especially in cases resistant to standard angioplasty. Their ability to provide controlled plaque modification without significant vessel trauma is gaining strong clinical acceptance globally.

Drivers:

1. Rising Cardiovascular Disease Burden:

The growing incidence of coronary artery disease and peripheral artery disease worldwide is one of the key drivers. Scoring balloon catheters are especially effective in treating calcified and fibrotic lesions, which are becoming more prevalent in aging populations.

2. Growth in Minimally Invasive Surgeries:

The shift toward minimally invasive cardiac procedures is increasing demand for technologies that reduce procedure time and improve patient outcomes. Scoring balloon catheters help reduce the need for stents or further interventions.

3. Technological Advancements in Balloon Catheters:

Continuous R&D in catheter design, including enhancements in balloon material, scoring element configuration, and drug-coating capabilities, are contributing to superior procedural outcomes and market expansion.

Restraints:

1. High Cost of Advanced Devices:

Scoring balloon catheters are more expensive than conventional balloon catheters, which may hinder adoption in price-sensitive markets and institutions with limited budgets.

2. Limited Reimbursement in Emerging Markets:

Lack of favorable reimbursement policies for advanced angioplasty tools in some developing countries can restrict the growth potential of this market.

Opportunity:

1. Expanding Applications in Peripheral Arterial Disease:

While traditionally used for coronary interventions, scoring balloon catheters are increasingly being explored for peripheral arterial procedures, opening new market segments.

2. Growth in Ambulatory Surgical Centers (ASCs):

The rise of outpatient vascular procedures, particularly in ASCs, presents a growth opportunity, given the suitability of scoring balloon catheters for streamlined and effective interventions.

Market by System Type Insights:

The Semi-Compliant Scoring Balloon Catheters segment led the market in 2023 due to its balance between flexibility and vessel dilatation strength, making it suitable for complex lesions. This segment is anticipated to maintain dominance as new semi-compliant products with enhanced trackability and deliverability enter the market. However, Non-Compliant Balloons are expected to witness faster growth in highly calcified or resistant lesions where higher pressure and force are required.

Market by End-use Insights:

Hospitals accounted for the largest revenue share in 2023, driven by their comprehensive infrastructure and capacity to handle high-risk cardiovascular interventions. Ambulatory Surgical Centers (ASCs) are projected to experience the fastest growth during the forecast period owing to increased adoption of minimally invasive procedures in cost-effective and efficient settings.

Market by Regional Insights:

North America dominated the global scoring balloon catheters market in 2023, supported by advanced healthcare infrastructure, favorable reimbursement frameworks, and a high prevalence of cardiovascular diseases. Asia-Pacific is forecasted to register the highest growth rate through 2031 due to rising healthcare expenditure, rapid urbanization, and growing awareness of interventional procedures in countries like India, China, and South Korea.

Competitive Scenario:

Prominent players in the global scoring balloon catheters market include BD (Becton, Dickinson and Company), Boston Scientific Corporation, Medtronic, Cardionovum GmbH, AngioScore Inc. (now part of Spectranetics/Philips), Merit Medical Systems, Inc., and Biotronik SE & Co. KG. These companies are investing in R&D to develop next-generation catheters and entering strategic collaborations to expand their global footprint.

Scope of Work – Global Scoring Balloon Catheters Market

Report Metric Details

Market Size (2023) USD 156.4 million

Projected Market Size (2031) USD 262.1 million

CAGR (2023–2031) 6.8%